Flag of Burundi

Burundi

Destination photograph: Burundi
Bujumbura (Burundi) Coconut beach.jpg · Tequendamia · CC0, via Wikimedia Commons. Displayed at a reduced size; no image edits.

Burundi travel health

Sources checked

Overview

Travel to Burundi requires practical preparation: a valid yellow fever vaccination certificate is routinely required by the authorities, malaria is present countrywide year‑round, health-care access is limited outside major towns, and freshwater contact (Lake Tanganyika and some rivers) can expose you to schistosomiasis. Regional infectious‑disease events (notably a 2026 Bundibugyo‑virus Ebola outbreak in neighbouring countries and recurring cholera transmission) increase the importance of up‑to‑date routine immunizations, malaria prevention, safe water/food practices and a plan for rapid medical evacuation or insured private care if needed.

Entry requirement: yellow fever certificate

Burundi requires proof of yellow fever vaccination for arriving travellers (standard International Health Regulations practice for the country). Make sure you carry an official International Certificate of Vaccination or Prophylaxis (yellow card); fractional/experimental doses or undocumented vaccination may not meet entry rules—check with the nearest Burundian consulate if in doubt. CDC: Burundi country page UK Foreign Travel Advice: entry requirements CDC Yellow Book / IHR table.

Routine and recommended vaccinations

Bring routine vaccinations up to date before travel (MMR, tetanus‑diphtheria‑pertussis, polio, varicella, and age‑appropriate pneumococcal/HPV/others). In addition, most travellers to Burundi are advised to receive hepatitis A and typhoid vaccines because of food‑ and water‑borne exposure risk; hepatitis B vaccination is recommended for those who may have sexual contact, medical procedures or other blood exposure. Rabies pre‑exposure vaccination should be considered for travellers who will have prolonged stays, do fieldwork, work with animals or may face delayed access to post‑exposure care. Discuss influenza and COVID‑19 vaccinations with your clinician based on season and your personal risk. CDC: Burundi vaccinations & advice TravelHealthPro: country guidance.

Yellow fever — individual risk

Yellow fever virus is present in parts of Africa; vaccination is not only a border requirement but also a preventive measure for travellers with jungle or rural exposure. Vaccination decisions should weigh itinerary, duration and underlying medical risks; if you receive vaccine less than 10 days before travel, some countries may not accept it for entry. CDC: Yellow fever and entry requirements CDC: yellow fever risk areas in Africa.

Other health risks

This subsection summarises the main non‑vaccine health threats travellers commonly encounter in Burundi and practical prevention measures.

Malaria

Malaria (primarily Plasmodium falciparum) occurs throughout Burundi and is a leading cause of serious illness; CDC recommends that all travellers to Burundi take prescription antimalarial medication for prevention. Choose an antimalarial in discussion with a clinician (options commonly include atovaquone‑proguanil, doxycycline or mefloquine) based on your itinerary, health status, drug interactions and local resistance patterns. Rigorously avoid mosquito bites (long sleeves, permethrin‑treated clothing, insect repellent with DEET/icaridin, bed nets). CDC: malaria advice for Burundi CDC Emerging Infectious Diseases: recent malaria surveillance in northern Burundi.

Water‑ and food‑borne diseases (diarrhoea, cholera)

Acute diarrhoeal illness is common; travellers should use safe food and water practices (boil or filter water, avoid ice from uncertain sources, eat well‑cooked hot food, peel fruit). Burundi has experienced localized cholera transmission in recent years; when cholera is active in an area, avoid untreated water and raw foods and seek immediate care for severe watery diarrhoea and dehydration. CDC: cholera and traveller advice WHO: multi‑country cholera surveillance (regional context).

Schistosomiasis (freshwater exposure)

Schistosoma mansoni is endemic along Lake Tanganyika and in riverine/rice‑plain areas (e.g., Rusizi, parts of the Imbo plain). Swimming, wading or other freshwater contact can transmit infection; avoid freshwater exposure where transmission is known, and if you have freshwater contact consider testing 4–6 weeks after return. WHO/ESPEN: schistosomiasis overview and maps Research: schistosomiasis locations and control in Burundi.

Rabies and animal bites

Dog‑mediated rabies occurs in Burundi and access to timely post‑exposure prophylaxis (rabies immunoglobulin and vaccine) may be limited outside major urban centres. Avoid contact with dogs, bats and other mammals; if bitten or scratched wash the wound with soap and water immediately and seek urgent medical care. Consider pre‑exposure rabies vaccination for long stays, remote travel, or work with animals. CDC: rabies and animal‑bite guidance TravelHealthPro: rabies in Burundi.

Arboviruses (dengue, chikungunya) and other insect‑borne infections

Dengue and other Aedes‑mosquito transmitted infections occur in the region; urban mosquitoes bite during the day. Use daytime and nighttime bite prevention (repellent, clothing, screened accommodation). If you develop fever during or after travel seek prompt medical assessment because dengue can progress rapidly. CDC: dengue/arbovirus general advice TravelHealthPro: vector‑borne disease notes.

HIV, tuberculosis and routine care access

HIV prevalence in Burundi is lower than some neighbouring countries but exposure risks exist; travellers who may need ongoing HIV or TB care should plan continuity of treatment and carry documentation. Health facilities and laboratory services are limited outside Bujumbura and some provincial centres—arrange travel health insurance that covers medical evacuation and private care where needed. Government of Canada: health and services in Burundi CDC: health‑care access advice.

Current health alerts

Include only developments with clear, destination‑specific backing from public‑health authorities or surveillance reports.

Undiagnosed cluster in Mpanda (April 2026) — investigation

In April 2026 the Burundi Ministry of Health, supported by WHO, reported an investigation of an undiagnosed illness that sickened about 35 people (five deaths) in Mpanda district; WHO supported surveillance, sample testing and infection control measures. If your itinerary includes northern Bubanza/Mpanda areas monitor local guidance and avoid unprotected contact with sick people. WHO Regional Office for Africa: investigation in Mpanda.

Localized cholera transmission

WHO and regional surveillance report recurrent, focal cholera transmission in parts of Burundi; CDC notes recent localized cases in Bujumbura and Burunga divisions. During active transmission, practise strict water/food safety and seek urgent care for profuse watery diarrhoea. CDC: cholera risk and traveller advice WHO: regional cholera updates.

Regional Ebola (Bundibugyo) outbreak — cross‑border risk

During 2026 a large Bundibugyo‑virus Ebola outbreak occurred in the Democratic Republic of the Congo (DRC) and Uganda; WHO identifies immediate neighbours including Burundi as having high cross‑border risk and recommends intensified surveillance and readiness. This is a regional risk; there was no authoritative declaration of sustained transmission inside Burundi at the time of these checks, but travellers should follow WHO and national health updates while planning travel near border areas. WHO: Ebola Bundibugyo disease outbreak (DRC & Uganda) WHO AFRO: weekly external situation reports.

Before you travel

Plan at least 4–6 weeks before departure so vaccines can take effect and you can complete malaria prescriptions where needed.

Practical checklist

Confirm and carry an official yellow fever vaccination certificate; consult a travel‑medicine clinician for malaria prophylaxis and itinerary‑specific vaccine advice; update routine immunizations (MMR, tetanus); consider hepatitis A and typhoid vaccines; discuss rabies pre‑exposure vaccine if you will be in remote or animal‑exposed settings; avoid freshwater contact where schistosomiasis is present; pack insect repellent, a bed net if staying in basic accommodation, and a first‑aid kit; buy travel health insurance that includes evacuation and ensure you know where to access care in Bujumbura. CDC: Traveller checklist and country guidance TravelHealthPro: preparation advice.

Medical and safety planning

If you take regular medicines, carry sufficient supply in original packaging plus a copy of prescriptions. Learn contact details for the nearest embassy/consulate and major hospitals in Bujumbura. Because some outbreaks and security incidents affect border areas and service availability, plan alternative routes and evacuation options if your stay includes remote border regions. U.S. Department of State: country information and health‑care access.

This information summarizes published public‑health guidance. A travel‑health professional can advise on your itinerary, medical history and vaccination needs.

AI-generated landscape illustration inspired by Burundi
AI-generated illustration inspired by Burundi.

Burundi: recent disease outbreaks

Sources checked

Recent reports

Cholera (Vibrio cholerae) — ongoing transmission in Burundi

WHO’s Weekly Epidemiological Record and WHO regional reports show that cholera/acute watery diarrhoea (AWD) transmission in Burundi remained active during 2026; WHO reported 1,868 cumulative cholera/AWD cases and 4 deaths in Burundi for January–August 2026 and recorded 201 cases in the most recent 28‑day window (data cut‑off 30 August 2026). WHO WER (Vol.101, Issue 39, 2 Oct 2026). This is a human‑only event (cases are people) and matters to travellers because cholera causes acute watery diarrhoea and can spread where water, sanitation and hygiene (WASH) are inadequate; WHO and partners continue WASH and case‑management activities in affected areas. WHO WER (cholera update).

Measles — clusters linked to refugee populations and local transmission

WHO Regional Office for Africa reported active measles transmission affecting communities and refugee settlements in eastern Burundi, and described reactive vaccination campaigns to protect children in Congolese refugee camps (vaccination activities reported January 20–25, 2026). WHO AFRO, 6 Jul 2026. More recent regional surveillance compiled by Africa CDC lists Burundi among countries with ongoing measles activity and reports 1,411 suspected cases with 13 deaths in the item dated 20 September 2026 (Africa CDC weekly reporting). Africa CDC (situation report, 20 Sep 2026). This is human‑to‑human transmission (respiratory spread) and is of particular concern for unvaccinated children or travellers in contact with local communities or refugee camps; WHO/partners have been running targeted vaccination and surveillance in affected districts. WHO AFRO.

Mpox (monkeypox, clade Ib) — sustained but declining detection; surveillance ongoing

Burundi reported transmission of mpox (clade Ib) during 2024–2026 and has been included in WHO mpox situational reporting and regional monitoring; WHO weekly epidemiological reporting during September–October 2026 continued to list mpox among signals under observation in the African Region. WHO WER (Issue 38/39, Sep–Oct 2026). Recent peer‑reviewed analysis of cases in Bujumbura (published Sept 2026) describes local transmission dynamics during the earlier part of the outbreak and documents diagnostic scale‑up in Burundi. Journal article (Sep 2026). The available evidence indicates ongoing surveillance and response rather than an explosive new surge; this is a human viral infection and remains relevant for travellers because clinical presentation can be variable and laboratory confirmation guides public‑health actions. WHO WER.

Ebola (regional Bundibugyo virus outbreak) — cross‑border risk and entry screening measures in Burundi

An Ebola (Bundibugyo ebolavirus) outbreak in neighbouring countries (DRC, Uganda and others) prompted Burundi to maintain enhanced preparedness and point‑of‑entry surveillance in 2026. WHO’s weekly reporting recorded new Ebola Disease News items for the region in late 2026, and United Nations / partner updates in August 2026 and Burundi government communications in October 2026 describe strengthened screening and readiness activities at borders and airports. WHO WER (2 Oct 2026); UN / partner update (26 Aug 2026); Burundi embassy note (14 Oct 2026). Public reporting and Burundi authorities describe measures that have been implemented or reinforced at entry points: traveller health/declaration forms, temperature checks and syndromic screening for travellers from affected countries (measures apply specifically to arrivals from or recently in Ebola‑affected areas). UN / Burundi reports.

Summary

These entries are a dated snapshot (sources checked 27 October 2026). Conditions can change quickly; travellers should consult the country health guide and the destination’s public‑health authority, and check WHO/Africa CDC and their own government travel health advice for up‑to‑date requirements (for example temporary entry screening or vaccination documentation) before and during travel.